While the online tools makes clear consumers can use it without obligation, the therapy section give patients information on AstraZeneca products.
The role of digital health technology in managing chronic disease continues to expand, with companies vying for everything from tracking people’s steps to offering the evidence-based National Diabetes Prevention Program (DPP).
The pharmaceutical maker AstraZeneca, whose treatments include dapagliflozin (Farxiga) for diabetes and rosuvastatin (Crestor) to lower cholesterol, joined the fray in 2014 with Fit2Me, a free diet and lifestyle program aimed at those with type 2 diabetes (T2D). Today, the drugmaker announced that Fit2Me, which already has 1.4 million users, will now feature support for patients with cardiovascular risk and disease.
With the update, the program now addresses the country’s 5 most prevalent health conditions: T2D, high cholesterol, high blood pressure, and triglycerides, and heart attack, according to a statement from AstraZeneca. The online program, which covers food choices, exercise options, therapy selection, and support services, “personalizes each user’s plan to accommodate their food and activity preferences,” the statement said.
While the online program makes clear that consumers can use the material without obligation, part of the therapy section advises patients on how to access “information on type 2 diabetes treatment options from AstraZeneca you can discuss with your doctor.”
The upgrade includes a new feature, Fit My Fridge, which helps users prepare healthy meals with ingredients they already have at home, offering help for busy professionals who cannot plan for every meal. More than 10,000 recipes based on guidelines from the American Diabetes Association and American Heart Association are available. The online program is available in mobile formats, the statement said.
Adding a cardiovascular element will “differentiate” Fit2Me from other online programs, according to the statement, making it “one of the only health management tools that allows people to create a customized diet and exercise plan based on food and exercise preferences, as well as health challenge areas.”
“People living with cardiovascular disease frequently deal with a wide range of risk factors that impact everyday health but, importantly, many of these risk factors are modifiable,” said William E. Boden, MD, Scientific Director, Clinical Trials Network, VA Boston Healthcare System. Having a free program like Fit2Me helps people with diabetes or other chronic conditions create sustainable lifestyle changes, he said.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More